Merck & Co. Inc. One Merck Drive PO Box 100 Whitehouse Station,
NJ 08889-0100 United States - Map Phone: 908-423-1000 Fax: 908-298-7082 Website: http://www.merck.com
Merck & Co., Inc. provides various health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. The company provides human health pharmaceutical products, such as therapeutic and preventive agents for the treatment of human disorders in the areas of cardiovascular, diabetes and obesity, respiratory, immunology infectious diseases, neurosciences and ophthalmology, oncology, vaccines, and women's health and endocrine. It also offers vaccines, including preventive pediatric, adolescent, and adult vaccines. In addition, the company discovers, develops, manufactures, and markets antibiotics, anti-inflammatory products, vaccines, products for the treatment of fertility disorders, and parasiticides for cattle, swine, horses, poultry, dogs, cats, salmons, and fish. Further, it manufactures and sells over-the-counter product line, including non-drowsy antihistamines; treatment for occasional constipation; decongestant-free cold/flu medicine for people with high blood pressure; nasal decongestant spray; and treatment for frequent heartburn. Additionally, the company provides foot care products comprising topical antifungal, and foot and sneaker odor/wetness products; and sun care products consisting of sun care lotions, sprays, and dry oils. It serves drug wholesalers and retailers, hospitals, government agencies, physicians, physician distributors, veterinarians, animal producers, and managed health care providers, as well as food chain and mass merchandiser outlets in the United States and internationally. The company has joint venture agreements with Sanofi Pasteur S.A. and AstraZeneca LP. Merck & Co., Inc. was founded in 1891 and is headquartered in Whitehouse Station, New Jersey. Key Statistics
| |
| Merck & Co. Inc.’s Governance Risk Indicator (GRI®) as of May 1, 2012 is: Audit (Low Concern), Board (Low Concern), Compensation (Low Concern), Shareholder Rights (Low Concern). | | Brought to you by Institutional Shareholder Services (ISS) |
| | Pay | Exercised | Mr. Kenneth C. Frazier ,
57 Chairman, Chief Exec. Officer, Pres and Pres of Global Human Health | 4.65M | 0.00 | Mr. Peter N. Kellogg ,
55 Chief Financial Officer and Exec. VP | 2.18M | 0.00 | Dr. Peter S. Kim Ph.D.,
53 Exec. VP and Pres of Merck Research Laboratories | 2.45M | 0.00 | Mr. Adam H. Schechter ,
47 Exec. VP and Pres of Global Human Health | 2.30M | 0.00 | Mr. Bruce N. Kuhlik ,
55 Exec. VP and Gen. Counsel | 1.83M | 0.00 |
|
| | Amounts are as of Dec 30, 2011 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year. | | Currency in USD. |
|